ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2126

The Utility of Digital Activity Fluorescence Optical Imaging in Quantifying Hand and Wrist Inflammation in Rheumatic Diseases

Yogan Kisten1, Noémi Györi1, Hamed Rezaei2,3, Adrian Levitsky4, Anna Karlsson1, Erik af Klint3 and Ronald van Vollenhoven3,5, 1Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute,Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Stockholm, Sweden, 2Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 3Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The rheumatology clinic of the Karolinska University Hospital, Stockholm, Sweden, 4The Karolinska Institute,Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Stockholm, Sweden, 5Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, imaging techniques, Synovitis, ultrasonography and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Various Imaging Techniques

Session Type: Abstract Submissions (ACR)

Background/Purpose

The objective detection and quantification of disease activity in its earliest pathophysiological stage is critical for achieving optimal therapy results. Fluorescence optical imaging (FOI) is a novel imaging modality for the hands & wrists, and automated quantification of the ensuing images using DACT (Disease ACTivity)-FOI as a novel algorithm representing activity. This study was designed to determine the utility of FOI as a diagnostic tool, and whether it could be used in lieu of color/power Doppler ultrasound (US) to quantify and ascertain apparent & non-apparent active synovitis

Methods

A total of 872 hand/wrist joints in 26 patients (18 female, 8 male, average age 51.5 years) with various rheumatic diseases (RA: 12, JIA, SLE, DM, FM, PsA & polyarthritis 1-2 each) were examined by standard clinical assessment, US and DACT-FOI. Joints swollen & tender or swollen only were considered clinically inflamed. Active synovitis was defined as having synovial thickening & Doppler activity on US. Joints positive by FOI displayed abnormal focal optical intensities by visual inspection. Silent synovitis was defined as showing synovitis by US but not clinically. The DACT value was digitally quantified per patient by an automated computer-based algorithm of the composite image (240 frames). After clinical, US and FOI positive joints for each hand were calculated, the sensitivity, specificity & kappa statistics computed & compared with the mean DACT values for all patients

Results

Out of 872 joints, 242 (16%) were inflamed clinically, 241 (28%) by US, and 229 (26%) by FOI. There was moderate agreement for synovitis detection between clinical examination & US (kappa 0.524 ± 0.033; 95% CI: 0.459 – 0.589) and between clinical examination & FOI (kappa 0.450 ± 0.035; 95% CI: 0.381 – 0.519). Of the 241 inflamed joints by US, 196 (81%) were also inflamed by FOI, while only 119 (49%) were inflamed clinically. Agreement between US and FOI in synovitis detection was good (kappa 0.773 ± 0.024; 95% CI: 0.725 – 0.821). Depending on the gold standard used to define inflammation, FOI was 73-83% sensitive and 86-95% specific for detecting synovitis.

Out of 730 non-inflamed joints by clinical examination, 608 (83%) were non-inflamed by US and 605 (83%) were non-inflamed by FOI. Of these clinically non-inflamed joints, 122 (17%) were inflamed by US. For detecting silent synovitis, FOI was 80% (98/122) sensitive and 96% (581/608) specific.

The number (mean ±SD) of active joints detected by clinical, US and FOI was 5.4 ±7.6; 9.4 ±9.8; and 9.3 ±9.7 respectively, and the overall automated disease activity DACT-FOI was 4.3 ±2.1. There was a strong positive correlation (r = 0.556; p=0.003) between the clinical detection of synovitis & DACT-FOI. The mean DACT values also correlated significantly with US (r = 0.479; p=0.013) and semi-quantitative FOI (r = 0.515; p=0.007)

Conclusion

FOI and the automated analysis DACT-FOI were technically feasible with high reproducibility and agreement with clinical scoring & US. For detecting synovitis semi-quantitatively, FOI had a lower sensitivity but similar specificity compared to US. FOI may be particularly useful in identifying patients with clinically non-apparent hand/wrist inflammation (silent synovitis)


Disclosure:

Y. Kisten,
None;

N. Györi,
None;

H. Rezaei,
None;

A. Levitsky,
None;

A. Karlsson,
None;

E. af Klint,
None;

R. van Vollenhoven,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-utility-of-digital-activity-fluorescence-optical-imaging-in-quantifying-hand-and-wrist-inflammation-in-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology